Summit Therapeutics Inc. (SMMT) Ownership

$19.85

$0.1 (-0.5%)
Last update: 04:00 PM EST
Day's range
$19.51
Day's range
$20.38

Summit Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAKER BROS. ADVISORS LP 05/15/2025 24.42 M $471.16 M   0.00% 3.31%
VANGUARD GROUP INC 05/09/2025 11.64 M $224.55 M   -0.26% 1.58%
FMR LLC 05/12/2025 9.34 M $180.13 M   15.93% 1.27%
BLACKROCK, INC. 05/02/2025 8.40 M $161.99 M   -0.40% 1.14%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 6.56 M $126.50 M   0.00% 0.89%
STATE STREET CORP 05/15/2025 4.85 M $93.58 M   -13.41% 0.66%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 3.28 M $63.38 M   2.63% 0.45%
PICTET ASSET MANAGEMENT HOLDING SA 05/05/2025 2.66 M $52.14 M   91.86% 0.36%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 1.70 M $32.85 M   339.82% 0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 1.46 M $28.18 M   -1.64% 0.20%
UBS GROUP AG 05/13/2025 1.26 M $24.39 M   6.56% 0.17%
ABRDN PLC 05/13/2025 1.20 M $23.16 M   -6.94% 0.16%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 1.10 M $21.19 M   122.73% 0.15%
CITADEL ADVISORS LLC 05/15/2025 998.74 K $19.27 M   432.93% 0.14%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2025 995.00 K $19.19 M   -5.60% 0.13%
MILLENNIUM MANAGEMENT LLC 05/15/2025 887.01 K $17.11 M   -56.73% 0.12%
NORTHERN TRUST CORP 05/13/2025 843.65 K $16.27 M   -3.18% 0.11%
CANDRIAM S.C.A. 05/14/2025 838.52 K $16.18 M   -0.48% 0.11%
TD ASSET MANAGEMENT INC 05/07/2025 807.19 K $15.57 M   -3.67% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 750.10 K $14.47 M   144.49% 0.10%
SIREN, L.L.C. 05/23/2025 695.00 K $13.41 M   100.00% 0.09%
TWIN TREE MANAGEMENT, LP 05/15/2025 653.60 K $12.61 M   -43.99% 0.09%
JPMORGAN CHASE & CO 05/12/2025 575.62 K $11.10 M   312.39% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 574.80 K $11.09 M   46.22% 0.08%
GOLDMAN SACHS GROUP INC 05/16/2025 572.79 K $11.05 M   -37.06% 0.08%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 538.00 K $10.38 M   100.00% 0.07%
JANE STREET GROUP, LLC 05/19/2025 506.10 K $9.76 M   29.54% 0.07%
MORGAN STANLEY 05/15/2025 478.13 K $9.22 M   -14.77% 0.06%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2025 466.16 K $8.99 M   -2.23% 0.06%
DEUTSCHE BANK AG\ 05/09/2025 427.62 K $8.25 M   -10.69% 0.06%
CUTTER CAPITAL MANAGEMENT, LP 05/15/2025 400.00 K $7.72 M   100.00% 0.05%
POLYMER CAPITAL MANAGEMENT (HK) LTD 05/15/2025 396.18 K $7.64 M   80.23% 0.05%
CITADEL ADVISORS LLC 05/15/2025 394.60 K $7.61 M   25.15% 0.05%
INVESCO LTD. 05/12/2025 389.71 K $7.52 M   -2.34% 0.05%
BANK OF AMERICA CORP /DE/ 05/15/2025 369.22 K $7.12 M   -14.45% 0.05%
QVT FINANCIAL LP 05/15/2025 360.52 K $6.95 M   0.00% 0.05%
BANK OF NEW YORK MELLON CORP 04/29/2025 340.78 K $6.57 M   2.18% 0.05%
TWIN TREE MANAGEMENT, LP 05/15/2025 339.09 K $6.54 M   -31.61% 0.05%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 322.10 K $6.21 M   100.00% 0.04%
E FUND MANAGEMENT CO., LTD. 05/13/2025 295.62 K $5.70 M   -0.23% 0.04%
CITIGROUP INC 05/12/2025 295.42 K $5.70 M   16.29% 0.04%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 286.03 K $5.52 M   39.30% 0.04%
CITADEL ADVISORS LLC 05/15/2025 256.60 K $4.95 M   7.36% 0.03%
BARCLAYS PLC 05/15/2025 255.61 K $4.93 M   -22.58% 0.03%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 253.50 K $4.89 M   228.26% 0.03%
GREAT POINT PARTNERS LLC 05/15/2025 250.00 K $4.82 M   100.00% 0.03%
PRINCIPAL FINANCIAL GROUP INC 04/28/2025 246.43 K $4.75 M   20.12% 0.03%
05/12/2025 235.89 K $4.55 M   100.00% 0.03%
SCHRODER INVESTMENT MANAGEMENT GROUP 05/13/2025 233.60 K $4.75 M   100.00% 0.03%
RAFFERTY ASSET MANAGEMENT, LLC 05/14/2025 229.74 K $4.43 M   -26.29% 0.03%

Summit Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 229 institutional investors and hedge funds held shares of Summit Therapeutics Inc.. The most heavily invested institutionals were:

BAKER BROS. ADVISORS LP: 24.42 M

VANGUARD GROUP INC: 11.64 M

FMR LLC: 9.34 M

BlackRock, Inc.: 8.4 M

PRICE T ROWE ASSOCIATES INC /MD/: 6.56 M

STATE STREET CORP: 4.85 M

13.24% of Summit Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 110.75 M shares in the last 24 months. This purchase volume represents approximately $2.20 B in transactions.